
Would you buy ‘an eye lift in a bottle'?
Inspired by the results of his clinical treatments, the renowned plastic surgeon founded 111SKIN in 2012. The surgically-precise skincare brand was an instant hit with celebrities like Cate Blanchett and Victoria Beckham, reporting revenues of £20.3 million in 2023.
• This article contains affiliate links that can earn us revenue
Like many doctor-led brands, 111SKIN's formulas are backed by breakthrough skin science, designed to optimise skin health and deliver visible, targeted results. 'During my years as a plastic reconstructive surgeon at 111 Harley Street, I trialled many clinical-strength products to assist the healing process of my clients' post-surgery skin but found them all too aggressive and reactive to their sensitive conditions,' says Alexandrides. 'Convinced that the ideal post-surgery skincare ointment was non-existent, I designed my own skin healing formula.'
Inspired by the reparative properties of NAC (N-acetylcysteine) — a powerful antioxidant that can reinforce the skin's natural defences — Alexandrides created what is now 111SKIN's proprietary complex NAC Y2™. 'It is a patent complex of ingredients that we use in our products to yield dramatic results by repairing and soothing the skin,' Alexandrides says. 'The encapsulated formula promotes production of glutathione for antioxidant protection. It also stimulates collagen production and strengthening of the skin's barrier to enhance overall skin health.'
Many of 111SKIN's bestselling products include this beneficial combination of ingredients and are targeted to repair the skin and fight premature signs of ageing. Dubbed by those in the know as 'an eye lift in a bottle,' the Eye Lift Gel NAC Y²™ has been formulated to visibly reduce fine lines and dark circles while lifting and depuffing the under-eye area.
Alongside the NAC Y²™, the lightweight gel also contains Argireline — a powerful hexapeptide that Alexandrides says is the no-needle alternative to expression-freezing injectables — to help lift and sculpt the under-eye area. Silverskin extract improves moisture retention while shielding against external aggressors like UV radiation and pollution, while a bi-functional caffeine complex that targets signs of tiredness by boosting blood flow.
'As your skin drinks in the hydrating gel formula the expression-freezing effects of Argireline get to work, lifting and locking skin in place for a younger-looking appearance. Meanwhile, NAC Y²™ provides advanced protection against free radicals while caffeine helps to depuff, brighten, and reawaken tired eyes,' Alexandrides says.
111SKIN now boasts more than 65 products across the brand. Each surgically-precise formula is inspired by Alexandrides' clinical treatments at 111 Harley Street and complements them. The repair range — with the common thread of NAC Y²™ running through it — features a serum, daily moisturiser, night cream, and sunscreen, as well as one of the brand's much-loved facial sheet masks. They are all designed to help optimise the skin and slow down senescence — and for some, keep the knives and needles away.
Find out more and shop the full collection at 111skin.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Smith Douglas Homes Corp. (SDHC): A Bear Case Theory
We came across a bearish thesis on Smith Douglas Homes Corp. on Darius Dark Investing's Substack. In this article, we will summarize the bulls' thesis on SDHC. Smith Douglas Homes Corp.'s share was trading at $20.57 as of July 28th. SDHC's trailing and forward P/E were 11.56 and 15.95, respectively according to Yahoo Finance. Aerial view of a newly-constructed residential home in a suburban neighborhood. Smith Douglas Homes Corp. (NYSE: SDHC), which went public in January 2024, positioned itself as a disciplined growth story in the high-demand housing markets of the Southeastern and Southern U.S., focusing on resilient entry-level and empty-nester buyers. Its 'land-light' model, leveraging finished lots through option contracts, and an efficient operating culture under seasoned leadership, fueled rapid growth, with 2024 closings and revenue rising 25% and 28%, respectively. However, early 2025 revealed a stark reversal. While Q1 revenue grew 19% year-over-year, gross margins compressed sharply to 23.8%, pressured by rising lot costs and sales incentives, while net new orders stagnated at 768 homes. Backlog collapsed by 29% in units and 29% in value, foreshadowing weaker future revenue. Cash burn accelerated, with operating cash outflows surging to $34.9 million and leverage rising from 0.8% to 9.5%, eroding the balance sheet. SDHC's model, highly reliant on third-party developers, faces external risks, including affordability pressures from mortgage rates likely to remain above 6%, lumber price volatility, and potential U.S.–Canada softwood duties doubling. Competitive comparisons are unfavourable: Green Brick Partners' 31.2% gross margin and Dream Finders Homes' 18% growth in net orders highlight SDHC's operational underperformance. A $50 million buyback and insider purchases project confidence, yet with cash reserves halved, the move may reflect financial engineering ahead of declining earnings. The strategic framework remains sound, but the near-term outlook is fraught with margin compression, stagnating sales, and an eroding pipeline. With multiple quarters of likely weak results ahead, caution is warranted until the company demonstrates resilience through these headwinds. Previously, we covered a bullish thesis on Five Point Holdings, LLC (FPH) by Investing Intel in April 2025, which highlighted its strong liquidity, asset monetization, and reaffirmed earnings guidance, positioning it to benefit from resilient housing demand. The company's stock price has appreciated by approximately 4.88% since our coverage, as the thesis played out. Darius Dark Investing shares a contrarian view, stressing margin compression, weak orders, and collapsing backlog at peer Smith Douglas Homes Corp. Smith Douglas Homes Corp. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 7 hedge fund portfolios held SDHC at the end of the first quarter which was 10 in the previous quarter. While we acknowledge the potential of SDHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
Shake Shack Inc. (SHAK): A Bear Case Theory
We came across a bearish thesis on Shake Shack Inc. on Valueinvesting subreddit by stressed_senior110. In this article, we will summarize the bulls' thesis on SHAK. Shake Shack Inc.'s share was trading at $138.18 as of July 28th. SHAK's trailing and forward P/E were 476.48 and 99.01, respectively according to Yahoo Finance. Shake Shack (SHAK) has surged ~72% since April 2025, driven by optimism around margin expansion, store growth guidance, and marketing under CEO Rob Lynch, but the rally rests on shaky fundamentals. Comparable sales (SSS) have recovered to low single-digit growth post-April due largely to aggressive promotions and limited-time offers (LTOs), masking longer-term traffic declines. Management's plan to grow to 1,500 company-owned stores by 2037 appears overly ambitious given intensifying competition and the limited whitespace in Tier 1 markets, where rivals like Five Guys have already slowed expansion. The Street is also overly optimistic on margin expansion, forecasting a 220 bps increase through 2027, but most gains to date have come from low-hanging cost cuts such as labor reductions. Promotional deals touted as margin accretive, like free items with modest minimum spend, risk cannibalizing average order value rather than driving incremental revenue. Heavy reliance on LTOs, exemplified by the Dubai Chocolate Shake temporarily accounting for 5% of sales, creates a vulnerability as colder months approach and seasonal demand fades. Analyst extrapolations of these outsized results appear unrealistic, setting up for negative revisions. Meanwhile, Lynch's operational track record raises concerns: his tenure at Papa John's saw deteriorating product quality, strained franchisee relations, and a 50% stock decline post-COVID, all blamed on external pressures but widely attributed to cost-cutting that compromised brand equity. SHAK's value proposition hinges on quality ingredients, making further erosion of this core differentiator particularly risky. Any guidance cut, LTO pullback, or quality misstep could trigger a sharp rerating from current levels. Previously, we covered a bullish thesis on Wingstop Inc. (WING) by Monopolistic Investor in March 2025, which highlighted strong operating efficiency, rapid expansion plans, and upside potential despite high leverage. The company's stock price has appreciated by approximately 29% since our coverage, as growth and margins continued to impress. The thesis still stands on long-term expansion. stressed_senior110 shares a contrarian view on Shake Shack Inc. (SHAK), emphasizing ambitious growth and heavy reliance on promotions in the same fast-casual space. Shake Shack Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 39 hedge fund portfolios held SHAK at the end of the first quarter which was 43 in the previous quarter. While we acknowledge the potential of SHAK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
IN CASE YOU MISSED IT: Sean 'Diddy' Combs' ex writes letter supporting his release
Virginia Huynh, has written a letter to the judge pushing for him to be released. The ex-girlfriend was supposed to testify against him in his criminal case, but dropped out days before the trial began. She has now penned a letter pushing for Combs' release on bail. Huynh, who goes by Gina, was part of the prosecution's case against Combs, initially anonymously referred to as Victim-3. Before the trial began, prosecutors alerted the court that they could no longer locate Victim-3 and had lost touch with her and her attorney.